Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation

Detalhes bibliográficos
Autor(a) principal: Cucielo, Maira Smaniotto [UNESP]
Data de Publicação: 2022
Outros Autores: Cesário, Roberta Carvalho [UNESP], Silveira, Henrique Spaulonci [UNESP], Gaiotte, Letícia Barbosa [UNESP], Santos, Sérgio Alexandre Alcantara dos [UNESP], Zuccari, Debora Aparecida Pires de Campos, Seiva, Fábio Rodrigues Ferreira, Reiter, Russel J., Chuffa, Luiz Gustavo de Almeida [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3390/molecules27144350
http://hdl.handle.net/11449/240427
Resumo: Ovarian cancer (OC) is the most lethal gynecologic malignancy, and melatonin has shown various antitumor properties. Herein, we investigated the influence of melatonin therapy on energy metabolism and mitochondrial integrity in SKOV-3 cells and tested whether its effects depended on MT1 receptor activation. SKOV-3 cells were exposed to different melatonin concentrations, and experimental groups were divided as to the presence of MT1 receptors (melatonin groups) or receptor absence by RNAi silencing (siRNA MT1+melatonin). Intracellular melatonin levels increased after treatment with melatonin independent of the MT1. The mitochondrial membrane potential of SKOV-3 cells decreased in the group treated with the highest melatonin concentration. Melatonin reduced cellular glucose consumption, while MT1 knockdown increased its consumption. Interconversion of lactate to pyruvate increased after treatment with melatonin and was remarkable in siRNA MT1 groups. Moreover, lactate dehydrogenase activity decreased with melatonin and increased after MT1 silencing at all concentrations. The UCSC XenaBrowser tool showed a positive correlation between the human ASMTL gene and the ATP synthase genes, succinate dehydrogenase gene (SDHD), and pyruvate dehydrogenase genes (PDHA and PDHB). We conclude that melatonin changes the glycolytic phenotype and mitochondrial integrity of SKOV-3 cells independent of the MT1 receptor, thus decreasing the survival advantage of OC cells.
id UNSP_3ad128544d3bda59740a64f549cb71e6
oai_identifier_str oai:repositorio.unesp.br:11449/240427
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activationglucosemelatoninmitochondrial metabolismovarian cancerSKOV-3 cellsWarburg effectOvarian cancer (OC) is the most lethal gynecologic malignancy, and melatonin has shown various antitumor properties. Herein, we investigated the influence of melatonin therapy on energy metabolism and mitochondrial integrity in SKOV-3 cells and tested whether its effects depended on MT1 receptor activation. SKOV-3 cells were exposed to different melatonin concentrations, and experimental groups were divided as to the presence of MT1 receptors (melatonin groups) or receptor absence by RNAi silencing (siRNA MT1+melatonin). Intracellular melatonin levels increased after treatment with melatonin independent of the MT1. The mitochondrial membrane potential of SKOV-3 cells decreased in the group treated with the highest melatonin concentration. Melatonin reduced cellular glucose consumption, while MT1 knockdown increased its consumption. Interconversion of lactate to pyruvate increased after treatment with melatonin and was remarkable in siRNA MT1 groups. Moreover, lactate dehydrogenase activity decreased with melatonin and increased after MT1 silencing at all concentrations. The UCSC XenaBrowser tool showed a positive correlation between the human ASMTL gene and the ATP synthase genes, succinate dehydrogenase gene (SDHD), and pyruvate dehydrogenase genes (PDHA and PDHB). We conclude that melatonin changes the glycolytic phenotype and mitochondrial integrity of SKOV-3 cells independent of the MT1 receptor, thus decreasing the survival advantage of OC cells.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Structural and Functional Biology Institute of Biosciences UNESP—São Paulo State University, São PauloCancer Molecular Research Laboratory (LIMC) FAMERP Department of Molecular Biology, São PauloBiological Science Center Department of Biology Luiz Meneghel Campus Universidade Estadual do Norte do Paraná—UENP, ParanáDepartment of Cell Systems and Anatomy UT HealthDepartment of Structural and Functional Biology Institute of Biosciences UNESP—São Paulo State University, São PauloFAPESP: 2018/15797-5FAPESP: 2019/00906-6Universidade Estadual Paulista (UNESP)FAMERPUniversidade Estadual do Norte do Paraná—UENPUT HealthCucielo, Maira Smaniotto [UNESP]Cesário, Roberta Carvalho [UNESP]Silveira, Henrique Spaulonci [UNESP]Gaiotte, Letícia Barbosa [UNESP]Santos, Sérgio Alexandre Alcantara dos [UNESP]Zuccari, Debora Aparecida Pires de CamposSeiva, Fábio Rodrigues FerreiraReiter, Russel J.Chuffa, Luiz Gustavo de Almeida [UNESP]2023-03-01T20:16:41Z2023-03-01T20:16:41Z2022-07-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.3390/molecules27144350Molecules, v. 27, n. 14, 2022.1420-3049http://hdl.handle.net/11449/24042710.3390/molecules271443502-s2.0-85133782148Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengMoleculesinfo:eu-repo/semantics/openAccess2023-03-01T20:16:41Zoai:repositorio.unesp.br:11449/240427Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-03-01T20:16:41Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
title Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
spellingShingle Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
Cucielo, Maira Smaniotto [UNESP]
glucose
melatonin
mitochondrial metabolism
ovarian cancer
SKOV-3 cells
Warburg effect
title_short Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
title_full Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
title_fullStr Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
title_full_unstemmed Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
title_sort Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
author Cucielo, Maira Smaniotto [UNESP]
author_facet Cucielo, Maira Smaniotto [UNESP]
Cesário, Roberta Carvalho [UNESP]
Silveira, Henrique Spaulonci [UNESP]
Gaiotte, Letícia Barbosa [UNESP]
Santos, Sérgio Alexandre Alcantara dos [UNESP]
Zuccari, Debora Aparecida Pires de Campos
Seiva, Fábio Rodrigues Ferreira
Reiter, Russel J.
Chuffa, Luiz Gustavo de Almeida [UNESP]
author_role author
author2 Cesário, Roberta Carvalho [UNESP]
Silveira, Henrique Spaulonci [UNESP]
Gaiotte, Letícia Barbosa [UNESP]
Santos, Sérgio Alexandre Alcantara dos [UNESP]
Zuccari, Debora Aparecida Pires de Campos
Seiva, Fábio Rodrigues Ferreira
Reiter, Russel J.
Chuffa, Luiz Gustavo de Almeida [UNESP]
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
FAMERP
Universidade Estadual do Norte do Paraná—UENP
UT Health
dc.contributor.author.fl_str_mv Cucielo, Maira Smaniotto [UNESP]
Cesário, Roberta Carvalho [UNESP]
Silveira, Henrique Spaulonci [UNESP]
Gaiotte, Letícia Barbosa [UNESP]
Santos, Sérgio Alexandre Alcantara dos [UNESP]
Zuccari, Debora Aparecida Pires de Campos
Seiva, Fábio Rodrigues Ferreira
Reiter, Russel J.
Chuffa, Luiz Gustavo de Almeida [UNESP]
dc.subject.por.fl_str_mv glucose
melatonin
mitochondrial metabolism
ovarian cancer
SKOV-3 cells
Warburg effect
topic glucose
melatonin
mitochondrial metabolism
ovarian cancer
SKOV-3 cells
Warburg effect
description Ovarian cancer (OC) is the most lethal gynecologic malignancy, and melatonin has shown various antitumor properties. Herein, we investigated the influence of melatonin therapy on energy metabolism and mitochondrial integrity in SKOV-3 cells and tested whether its effects depended on MT1 receptor activation. SKOV-3 cells were exposed to different melatonin concentrations, and experimental groups were divided as to the presence of MT1 receptors (melatonin groups) or receptor absence by RNAi silencing (siRNA MT1+melatonin). Intracellular melatonin levels increased after treatment with melatonin independent of the MT1. The mitochondrial membrane potential of SKOV-3 cells decreased in the group treated with the highest melatonin concentration. Melatonin reduced cellular glucose consumption, while MT1 knockdown increased its consumption. Interconversion of lactate to pyruvate increased after treatment with melatonin and was remarkable in siRNA MT1 groups. Moreover, lactate dehydrogenase activity decreased with melatonin and increased after MT1 silencing at all concentrations. The UCSC XenaBrowser tool showed a positive correlation between the human ASMTL gene and the ATP synthase genes, succinate dehydrogenase gene (SDHD), and pyruvate dehydrogenase genes (PDHA and PDHB). We conclude that melatonin changes the glycolytic phenotype and mitochondrial integrity of SKOV-3 cells independent of the MT1 receptor, thus decreasing the survival advantage of OC cells.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-01
2023-03-01T20:16:41Z
2023-03-01T20:16:41Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3390/molecules27144350
Molecules, v. 27, n. 14, 2022.
1420-3049
http://hdl.handle.net/11449/240427
10.3390/molecules27144350
2-s2.0-85133782148
url http://dx.doi.org/10.3390/molecules27144350
http://hdl.handle.net/11449/240427
identifier_str_mv Molecules, v. 27, n. 14, 2022.
1420-3049
10.3390/molecules27144350
2-s2.0-85133782148
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Molecules
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799965412047192064